Production and Quality Control of Technetium-99m Radiolabeled Monoclonal Antibody

AbstractBackground and purpose: Binding a monoclonal antibody to tumor associated antigens is an effective method for cancer therapy because these agents can specifically target malignant cells. In fact, monoclonal antibodies are effective agents for diagnosis, grading and treatment of different kin...

Full description

Bibliographic Details
Main Authors: M.H. Babaei, Ph.D., Sh. Montaser kuhsari, Ph.D, R. Najafi, Ph.D, F. Joharidaha, Ph.D., M. Shafiei, M.Sc., P. Behradkia, M.Sc, N. Zarrabi ahrabi, M.Sc.
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2007-01-01
Series:Journal of Mazandaran University of Medical Sciences
Subjects:
Online Access:http://www.mazums.ac.ir/index.php?digital_library&do=downloadPdf&sid=526
_version_ 1818833224346894336
author M.H. Babaei, Ph.D.
Sh. Montaser kuhsari, Ph.D
R. Najafi, Ph.D
F. Joharidaha, Ph.D.
M. Shafiei, M.Sc.
P. Behradkia, M.Sc
N. Zarrabi ahrabi, M.Sc.
author_facet M.H. Babaei, Ph.D.
Sh. Montaser kuhsari, Ph.D
R. Najafi, Ph.D
F. Joharidaha, Ph.D.
M. Shafiei, M.Sc.
P. Behradkia, M.Sc
N. Zarrabi ahrabi, M.Sc.
author_sort M.H. Babaei, Ph.D.
collection DOAJ
description AbstractBackground and purpose: Binding a monoclonal antibody to tumor associated antigens is an effective method for cancer therapy because these agents can specifically target malignant cells. In fact, monoclonal antibodies are effective agents for diagnosis, grading and treatment of different kinds of cancers. In this research, a new monoclonal antibody against colon cancer cells was prepared and radiolabeling with technetium-99m evaluated.Materials and Methods: This research was done in three parts: preparation of hybridoma cell against colon cancer cell line (HT29), production of monoclonal antibody, determination of its characterizations and radiolabeling with technetium-99m.Results: mAb-D2 is an IgG1 with affinity constant of 7.2 × 109M-1 which can recognize CEA in tumor cells. Radiolabeling showed that 99mTc-HYNIC-mAb-D2 complex is stable, immunoradioactive, and has a desirable biodistribution.Conclusion: In this study, we gained a new radiopharmaceutical that may be a good candidate for radioimmunoscintigraphy.
first_indexed 2024-12-19T02:15:31Z
format Article
id doaj.art-7e81efc36233417c9a16f480de3954f9
institution Directory Open Access Journal
issn 1735-9260
1735-9279
language English
last_indexed 2024-12-19T02:15:31Z
publishDate 2007-01-01
publisher Mazandaran University of Medical Sciences
record_format Article
series Journal of Mazandaran University of Medical Sciences
spelling doaj.art-7e81efc36233417c9a16f480de3954f92022-12-21T20:40:27ZengMazandaran University of Medical SciencesJournal of Mazandaran University of Medical Sciences1735-92601735-92792007-01-011760613Production and Quality Control of Technetium-99m Radiolabeled Monoclonal AntibodyM.H. Babaei, Ph.D.Sh. Montaser kuhsari, Ph.DR. Najafi, Ph.DF. Joharidaha, Ph.D.M. Shafiei, M.Sc.P. Behradkia, M.ScN. Zarrabi ahrabi, M.Sc.AbstractBackground and purpose: Binding a monoclonal antibody to tumor associated antigens is an effective method for cancer therapy because these agents can specifically target malignant cells. In fact, monoclonal antibodies are effective agents for diagnosis, grading and treatment of different kinds of cancers. In this research, a new monoclonal antibody against colon cancer cells was prepared and radiolabeling with technetium-99m evaluated.Materials and Methods: This research was done in three parts: preparation of hybridoma cell against colon cancer cell line (HT29), production of monoclonal antibody, determination of its characterizations and radiolabeling with technetium-99m.Results: mAb-D2 is an IgG1 with affinity constant of 7.2 × 109M-1 which can recognize CEA in tumor cells. Radiolabeling showed that 99mTc-HYNIC-mAb-D2 complex is stable, immunoradioactive, and has a desirable biodistribution.Conclusion: In this study, we gained a new radiopharmaceutical that may be a good candidate for radioimmunoscintigraphy.http://www.mazums.ac.ir/index.php?digital_library&do=downloadPdf&sid=526Monoclonal antibodyRadiopharmaceuticalTechnetium-99mRadioimmunoscintigraphyColon
spellingShingle M.H. Babaei, Ph.D.
Sh. Montaser kuhsari, Ph.D
R. Najafi, Ph.D
F. Joharidaha, Ph.D.
M. Shafiei, M.Sc.
P. Behradkia, M.Sc
N. Zarrabi ahrabi, M.Sc.
Production and Quality Control of Technetium-99m Radiolabeled Monoclonal Antibody
Journal of Mazandaran University of Medical Sciences
Monoclonal antibody
Radiopharmaceutical
Technetium-99m
Radioimmunoscintigraphy
Colon
title Production and Quality Control of Technetium-99m Radiolabeled Monoclonal Antibody
title_full Production and Quality Control of Technetium-99m Radiolabeled Monoclonal Antibody
title_fullStr Production and Quality Control of Technetium-99m Radiolabeled Monoclonal Antibody
title_full_unstemmed Production and Quality Control of Technetium-99m Radiolabeled Monoclonal Antibody
title_short Production and Quality Control of Technetium-99m Radiolabeled Monoclonal Antibody
title_sort production and quality control of technetium 99m radiolabeled monoclonal antibody
topic Monoclonal antibody
Radiopharmaceutical
Technetium-99m
Radioimmunoscintigraphy
Colon
url http://www.mazums.ac.ir/index.php?digital_library&do=downloadPdf&sid=526
work_keys_str_mv AT mhbabaeiphd productionandqualitycontroloftechnetium99mradiolabeledmonoclonalantibody
AT shmontaserkuhsariphd productionandqualitycontroloftechnetium99mradiolabeledmonoclonalantibody
AT rnajafiphd productionandqualitycontroloftechnetium99mradiolabeledmonoclonalantibody
AT fjoharidahaphd productionandqualitycontroloftechnetium99mradiolabeledmonoclonalantibody
AT mshafieimsc productionandqualitycontroloftechnetium99mradiolabeledmonoclonalantibody
AT pbehradkiamsc productionandqualitycontroloftechnetium99mradiolabeledmonoclonalantibody
AT nzarrabiahrabimsc productionandqualitycontroloftechnetium99mradiolabeledmonoclonalantibody